We are live on
!
Find out more
CBIO
Crescent Biopharma
CBIO
CBIO
80 hedge funds and large institutions have $535M invested in Crescent Biopharma in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
244% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 9
38% more funds holding
Funds holding: 58 → 80 (+22)
32% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 19
29% more capital invested
Capital invested by funds: $416M → $535M (+$119M)
0.02% more ownership
Funds ownership: 0.91% → 0.93% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
46% less call options, than puts
Call options by funds: $2.14M | Put options by funds: $3.96M
Holders
80
Holders Change
+22
Holders Change %
+37.93%
% of All Funds
1.81%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
31
Increased
25
Reduced
19
Closed
9
Calls
$2.14M
Puts
$3.96M
Net Calls
-$1.81M
Net Calls Change
-$1.62M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$18M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$9.48M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
+$8.98M |
| 4 |
Axa
Paris,
France
|
+$6.76M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$6.48M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$36.1M |
| 2 |
Millennium Management
New York
|
-$8.88M |
| 3 |
O
OrbiMed
New York
|
-$4.72M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.59M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.65M |
